Literature DB >> 525524

Ten years of clinical experiences with ethyldeoxyuridine.

K L Elze.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525524

Source DB:  PubMed          Journal:  Adv Ophthalmol        ISSN: 0065-3004


× No keyword cloud information.
  6 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.

Authors:  R F Schinazi; R T Scott; J Peters; V Rice; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

3.  Susceptibility of recent clinical isolates of herpes simplex virus to 5-ethyl-2'-deoxyuridine: preferential inhibition of herpes simplex virus type 2.

Authors:  C Z Teh; S L Sacks
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

4.  Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.

Authors:  Federico Focher; Andrea Lossani; Annalisa Verri; Silvio Spadari; Andrew Maioli; Joseph J Gambino; George E Wright; Richard Eberle; Darla H Black; Peter Medveczky; Maria Medveczky; David Shugar
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

Review 5.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

6.  Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs.

Authors:  S L Spruance; D J Freeman; N V Sheth
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.